The campaign inspires individuals to seek help in taking control of their weight-loss efforts with CONTRAVE, an established ...

Joe Breen, 38, is one of thousands of people whose experiences with GLP-1s such as Ozempic and Wegovy have radically changed their relationship with alcohol. Are these drugs the future for treating ...

The study was supported by a company that has combined the two drugs in ... mean weight loss was significantly greater in the high- and low-dose bupropion/naltrexone groups than in the placebo ...

Weight loss medications typically suppress a person ... Contrave belongs to a class of drugs known as bupropion/naltrexone. Bupropion is a type of antidepressant, whereas naltrexone is an ...

Humans have spent thousands of years experimenting with weight loss aids. While Ozempic and Wegovy may be generating ...

Further studies should include broader populations and head-to-head comparisons of bupropion/naltrexone with other active weight-loss agents ... of the two component drugs will require careful ...

Encouraged by her weight-loss progress, Breen decided to give another member of this class of drugs, known as GLP-1 agonists, a shot. Eight months after he stopped taking naltrexone, in April 2023 ...

But it is not necessarily the same thing as cost-saving. And in the case of the latest wave of weight loss drugs, right now at their current prices they are not even cost-effective, let alone cost ...

From heart and kidney health to addiction reduction, GLP-1 drugs like Ozempic and Mounjaro may help with more than just weight loss Steve Christo/Corbis/Corbis/Getty ...

Currax Pharmaceuticals is taking a page out of Lesley Gore’s playbook to remind patients that obesity doesn’t own them. The drugmaker launched a campaign supporting its weight loss medication ...

Research shows that people using Ozempic for weight loss can lose between 10-15 percent of their body weight over a year. It’s particularly effective for individuals who also have type 2 diabetes or ...